非清髓性异基因造血干细胞移植的创新与展望

Innovation and Prospect of Non-myeloablative Allogeneic Stem Cell Transplantation

非清髓性异基因造血干细胞移植(NST)是在传统异基因造血干细胞移植的基础上发展起来的新移植领域,它减轻了预处理强度并加强了移植前后的免疫处理。因其并发症轻、危险性小而有广泛的应用前景,也有许多未知领域有待继续探讨。

Non-myeloablative allogeneic stem cell transplantation (NST) is a new field that based on traditional allogenic stem cell transplantation (Allo-SCT). It lessens the dose of pretreatment and strengthens the immune therapy before and after transplantation. Because of less complications and low harm, NST has a broad foreground for application. However, there are also many fields unknown in NST that need further research.